NCT01911234
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Sponsor: NeoVacs
Phase: II
July 23, 2013
Arthritis
Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Sponsor: NeoVacs
Phase: II
July 23, 2013
Arthritis
Condition: Dermatitis
Sponsor: GlaxoSmithKline
Phase: 1
February 14, 2013
Dermatitis
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase 0 completed
December 1, 2011
Healthy,
Immune Disease - Autoimmune
mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Conditions: Uveal Melanoma
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a
April 14, 2009
Cancer - Melanoma
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II
March 25, 2008 |
3 References
Cancer - Brain & CNS
Condition: Renal Transplant
Sponsors: Hoffman-La Roche Inc.
Phase: IV
April 6, 2007
Transplant
Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients
Conditions: Colorectal Cancer, Liver Metastases
Sponsors: Radboud University
Phase I, II
September 27, 2005 |
5 References
Cancer - Colon/Colorectal,
Cancer - Liver
Immune Dysregulation in Children and Adults With Asthma
Conditions: Asthma, Lung Diseases
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Phase n/a
August 23, 2005
Asthma
Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People
Conditions: HIV Infections
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase II
January 29, 2003 |
3 References
HIV,
Immune Disease - Secondary